Lynx Dx
Sam Kiousis is a Clinical Laboratory Technician at LynxDx since June 2020, previously serving as a Research Assistant at John D Dingell VAMC and Karmanos Cancer Institute. With a background in research spanning over a decade, Sam Kiousis has focused on the immune response to tumors, specifically investigating the Kynurenine pathway's impact on gliomas, meningiomas, and metastatic brain tumors, as well as the role of activated microglia in glioblastoma multiforme. Sam Kiousis holds Post Graduate Studies in Molecular Biology and Human Genetics from Wayne State University, completed between 1985 and 1989.
This person is not in the org chart
This person is not in any teams
Lynx Dx
MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients.